You're reading the free version. Trader adds the live tape and alerts.
Start tracking
DNLI Sale Disclosure
Thornberry Nancy · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$14.6K
Thornberry Nancy Director
DNLI
Transaction date
Sep 2, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 2 days later
DNLI daily price context
Close on/before transaction
$22.85
Sep 2, 2026
First close after public filing
$22.08
Sep 8, 2026
30-day return after filing
-9.83%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 615 shares @ $23.74
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001797826-26-000006
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$261.93K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Denali Therapeutics Inc. DNLI | Sale | Sep 2, 2026 | $247.33K |
| Denali Therapeutics Inc. DNLI Current | Sale | Sep 2, 2026 | $14.6K |